ACCROPEUTICS Trademark

Trademark Overview


On Saturday, May 6, 2023, a trademark application was filed for ACCROPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ACCROPEUTICS trademark a serial number of 79374058. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, May 28, 2024. This trademark is owned by Accro Bioscience(Suzhou) Limited. The ACCROPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the prevention and treatment of inflammatory diseases, autoimmune diseases, cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases; Biological preparations for the prevention and treatment of inflammatory diseases, autoimmune diseases, cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases; chemical reagents for medical or veterinary purposes; medicines for the prevention and treatment of inflammatory diseases, autoimmune diseases, cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases; preparations of microorganisms for medical purposes; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of inflammatory diseases, autoimmune diseases, cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases; veterinary preparations for the prevention and treatment of infectious diseases; medicines for veterinary pu...

research and development of new products for others; technological research in the field of medicine and medical instruments; chemical analysis; chemistry consultation; chemical research; medical research; scientific research in the nature of conducting clinical trials for others; biological research; bacteriological research; cloud computing featuring software for accessing, reading, and tracking information in the field of medicine and medical devices
accropeutics

General Information


Serial Number79374058
Word MarkACCROPEUTICS
Filing DateSaturday, May 6, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, May 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of inflammatory diseases, autoimmune diseases, cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases; Biological preparations for the prevention and treatment of inflammatory diseases, autoimmune diseases, cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases; chemical reagents for medical or veterinary purposes; medicines for the prevention and treatment of inflammatory diseases, autoimmune diseases, cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases; preparations of microorganisms for medical purposes; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of inflammatory diseases, autoimmune diseases, cancer, neurodegenerative diseases, cardiovascular diseases, and infectious diseases; veterinary preparations for the prevention and treatment of infectious diseases; medicines for veterinary purposes, namely, veterinary preparations for the prevention and treatment of infectious diseases
Goods and Servicesresearch and development of new products for others; technological research in the field of medicine and medical instruments; chemical analysis; chemistry consultation; chemical research; medical research; scientific research in the nature of conducting clinical trials for others; biological research; bacteriological research; cloud computing featuring software for accessing, reading, and tracking information in the field of medicine and medical devices

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 14, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAccro Bioscience(Suzhou) Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCN

Trademark Events


Event DateEvent Description
Thursday, July 13, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 18, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, January 31, 2024ASSIGNED TO EXAMINER
Tuesday, February 6, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 7, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 28, 2024REFUSAL PROCESSED BY MPU
Monday, March 18, 2024REFUSAL PROCESSED BY IB
Tuesday, May 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 28, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 28, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 28, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB